Clinical Trial Update: Clinical Trial of Erlotinib and Pemetrexed for Maintenance Treatment in Lung Adenocarcinoma [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 clinical trial of erlotinib plus pemetrexed as maintenance therapy for Lung Adenocarcinoma. The current status of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Drugs mentioned

• Alimta (pemetrexed)
• Tarceva (erlotinib)

Snippet

Sponsor: Hunan Province Tumor Hospital | Conditions: Lung Adenocarcinoma | Phase 4 | Status: UNKNOWN